Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 48 out of 100. Mild cognitive impairment

Topic: Risk, prevention and care in population studies

Neurophysiological activity features and tau pet provided additional information to the clinical model when acquired up to ∼4 years prior to diagnosis, but their accuracy decreased at larger intervals. In contrast, the accuracy gained by incorporating Aβ PET or plasma biomarkers remained high up to 6 years before diagnosis (Figure 2). These observations were confirmed after running stepwise logistic regression on the model including all biomarkers, highlighting the contribution of age, sex, plasma p-tau217, Aβ and tau PET and neurophysiological activity for predicting MCI progression at different time intervals (Figure 3). Overall, our results delineate a timeline of the accuracy provided by different biomarkers for predicting progression to MCI. Such findings highlight the dynamic sensitivity of different biomarkers, which is dependent on the time lapse between biomarkers collection and clinical diagnosis. This is particularly relevant for future clinical trials that intend to use biomarkers for screening participants.

Key findings

Why it matters

This study found that the accuracy of different biomarkers for predicting progression to mild cognitive impairment depends on how long before diagnosis they are measured, with some remaining accurate up to six years prior. It is about biomarker timing for prediction and does not test any treatment, cure, or prevention.

Study details

How this study scored 48/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 48 of 100.48 of 100 points earned52 not earned

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 102 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Sylvia Villeneuve: h-index 48 (OpenAlex, whole career)
Institution's track record 1 / 3 McGill University: institution h-index 1,373 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41433380)
Free to read 2 / 2 Free to read
Total 48 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Rudolf, J. G., Wiesman, A. I., Baillet, S., & Villeneuve, S. (2025). Time‐dependent biomarker accuracy in forecasting mild cognitive impairment. Alzheimer s & Dementia. https://doi.org/10.1002/alz70862_110285

Vancouver

Rudolf JG, Wiesman AI, Baillet S, Villeneuve S. Time‐dependent biomarker accuracy in forecasting mild cognitive impairment. Alzheimer s & Dementia. 2025. doi:10.1002/alz70862_110285. PMID: 41433380.

BibTeX

@article{rudolf2025-41433380,
  author  = {Rudolf, Jonathan Gallego and Wiesman, Alex I. and Baillet, Sylvain and Villeneuve, Sylvia},
  title   = {{Time‐dependent biomarker accuracy in forecasting mild cognitive impairment}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70862_110285},
  pmid    = {41433380},
  url     = {https://doi.org/10.1002/alz70862_110285}
}

Related studies in Mild cognitive impairment

Also tagged “assessment”

840 studies in the library carry the topic tag “assessment”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Similar studies

More on Mild cognitive impairment

See all studies in Mild cognitive impairment →